Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Swine-Origin A/H1N1 Influenza Vaccine in Children and Adolescents
NCT00956202Phase 2Completed
- Sponsor
- Sanofi
- Start
- Aug 2009
- Primary completion
- Sep 2010
- Modality
- Live Biotherapeutic Products, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of influenza A (H1N1) 2009 monovalent vaccine in influenza, sponsored by Sanofi. Started Aug 2009; status: completed.
02
Drugs
influenza A (H1N1) 2009 monovalent vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00956202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00956202.